M7T — Mach7 Technologies Share Price
- AU$79.61m
- AU$57.28m
- AU$30.01m
- 68
- 57
- 37
- 56
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.53 | ||
Price to Tang. Book | 2.98 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 2.32 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -12.65% | ||
Return on Equity | -9.77% | ||
Operating Margin | -21.12% |
Financial Summary
Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | 18.86 | 19.03 | 27.08 | 30.46 | 30.01 | 36.66 | 43.31 | 26.28% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Mach7 Technologies Limited is an Australia-based medical imaging systems provider. The principal activity of the Company is the development and commercialization of medical imaging and data management software solutions for global healthcare enterprises. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7’s Enterprise Data Management solution consists of a Vendor Neutral Archive (VNA) and data administration tools, which allow for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the cloud. Enterprise Diagnostic Viewing offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. It offers its solutions across North America, Asia Pacific, and the Middle East region.
Directors
- David Chambers NEC
- Mike Lampron CEO
- Jenni Pilcher CFO
- Robert Bazzani NED
- Philippe Houssiau NED (58)
- Eliot Siegel NED
- Alister Spittle NED
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 20th, 1977
- Public Since
- November 30th, 2005
- No. of Employees
- 90
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Australian Stock Exchange - SEATS
- Shares in Issue
- 241,241,047

- Address
- Level 4, 100 Albert Road, MELBOURNE, 3205
- Web
- https://mach7t.com/
- Phone
- +61 396927222
- Auditors
- RSM Australia Partners
Upcoming Events for M7T
Q3 2025 Mach7 Technologies Ltd Activities Report
Full Year 2025 Mach7 Technologies Ltd Earnings Release
Similar to M7T
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
Aroa Biosurgery
Australian Stock Exchange - SEATS
FAQ
As of Today at 21:50 UTC, shares in Mach7 Technologies are trading at AU$0.33. This share price information is delayed by 15 minutes.
Shares in Mach7 Technologies last closed at AU$0.33 and the price had moved by -53.85% over the past 365 days. In terms of relative price strength the Mach7 Technologies share price has underperformed the ASX All Ordinaries Index by -55.52% over the past year.
The overall consensus recommendation for Mach7 Technologies is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreMach7 Technologies does not currently pay a dividend.
Mach7 Technologies does not currently pay a dividend.
Mach7 Technologies does not currently pay a dividend.
To buy shares in Mach7 Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.33, shares in Mach7 Technologies had a market capitalisation of AU$79.61m.
Here are the trading details for Mach7 Technologies:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: M7T
Based on an overall assessment of its quality, value and momentum Mach7 Technologies is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Mach7 Technologies is AU$1.17. That is 253.64% above the last closing price of AU$0.33.
Analysts covering Mach7 Technologies currently have a consensus Earnings Per Share (EPS) forecast of -AU$0.02 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mach7 Technologies. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -32.78%.
As of the last closing price of AU$0.33, shares in Mach7 Technologies were trading -25.9% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mach7 Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.33.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Mach7 Technologies' management team is headed by:
- David Chambers - NEC
- Mike Lampron - CEO
- Jenni Pilcher - CFO
- Robert Bazzani - NED
- Philippe Houssiau - NED
- Eliot Siegel - NED
- Alister Spittle - NED